Amphista Therapeutics

1-2 of 2 Articles
Clock icon 4 minutes

Amphista Therapeutics, a University of Dundee spin-out company, has announced a £38 million investment round that will further its work to develop new drugs for a range of diseases. Amphista is a biopharmaceutical company creating first-in-class therapeutics that harness the body’s natur

Clock icon 2 minutes

Amphista Therapeutics, a University of Dundee spin-out, has announced a multi-million-pound deal to develop first-in-class cancer therapeutics that harness the body’s natural processes to selectively and efficiently degrade and remove disease-causing proteins. The spin-out has announced the cl

1-2 of 2 Articles